Analysis Silence Therapeutics plc (SLN)
6/3/2024
Analysis of Silence Therapeutics plc (SLN)
Silence Therapeutics plc (SLN) has shown some volatility in its stock price over the past few days. The stock closed at 22.80 on the most recent trading day, with a high of 23.32 and a low of 21.80.The Relative Strength Index (RSI) is currently at 54.98, indicating a neutral sentiment in the market. The Moving Average Convergence Divergence (MACD) is slightly negative at -0.03, with the signal line at 0.02. This suggests a potential bearish signal in the short term.
Looking at the moving averages, the Simple Moving Average (SMA) is at 22.11, the Exponential Moving Average (EMA) is at 22.12, and the Weighted Moving Average (WMA) is at 22.14. These indicators show a relatively stable trend in the stock price.
Overall, based on the technical indicators, Silence Therapeutics plc appears to be in a consolidation phase with some bearish signals in the short term. Investors may want to closely monitor the stock for any potential changes in trend.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the net income has also shown a positive trend, rising from $57.4 billion in 2020 to $97 billion in 2023.
3. The company's EBITDA has also been increasing over the years, indicating improved operational efficiency.
4. The basic and diluted earnings per share (EPS) have remained relatively stable over the years, with slight fluctuations.
5. The company has been able to maintain a healthy gross profit margin, with gross profit increasing along with sales.
6. Operating income has also shown a positive trend, reflecting effective cost management strategies.
7. The company has been able to generate consistent income from its core operations, as seen in the net income from continuous operations.
8. Overall, the financial performance of the company seems to be on a positive trajectory, with increasing sales and profitability over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion and total debt of $104.59 billion, resulting in a current ratio of 1.037. The company has a book value per share of $4.837 and total cash per share of $4.379, with a total debt to equity ratio of 140.968.In terms of profitability, the company has a profit margin of 26.31% and an operating margin of 30.74%. The return on assets is 22.07% and the return on equity is 147.25%. The most recent quarter ended on March 31, 2024, with a fiscal year ending on September 30, 2023.
The income statement shows an EBITDA of $131.39 billion, revenue of $381.62 billion, and a net income to common of $100.39 billion. The diluted EPS is $6.43 and the revenue per share is $24.54. The company experienced a negative quarterly revenue growth of -4.3% and a negative quarterly earnings growth year over year of -2.2%.
In terms of stock statistics, the company has a short ratio of 1.53 and a short percent of shares outstanding of 0.65%. The float shares are 15.31 billion, with 99.29 million shares shorted. The shares outstanding are 15.33 billion, with 5.22% held by insiders and 57.59% held by institutions.
The valuation metrics show a PEG ratio of 26.32, a forward PE of 26.32, and a trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and a price to sales ratio of 7.65. The enterprise to EBITDA ratio is 22.76 and the enterprise to revenue ratio is 7.73. The market capitalization is $2.92 trillion.
In terms of stock price summary, the beta is 1.264, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The fifty-two-week low is $164.08, the high is $199.62, and the change is 6.85%.
Regarding dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of 1. The 5-year average dividend yield is 0.73% and the forward annual dividend yield is 0.53%. The trailing annual dividend rate is 0.97% and the trailing annual dividend yield is 0.51%. The last dividend date was on May 16, 2024, with an ex-dividend date on May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, long-term debt issuance, and payments, with significant fluctuations in values.
6. Investing activities indicate a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, showing growth trends in both the quarterly and annual performance over the specified periods.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be healthy.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of estimates, from a low of $164 to a high of $275, indicating some uncertainty in the market.
MACD of SLN
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
